SciELO - Scientific Electronic Library Online

vol.29 issue2Diagnostic Usefulness of Upper Gastrointestinal Endoscopy for Patients under 18 Years of AgeThe Use of NSAIDs Combined with Prophylactic Use of PPIs for Internal Medicine Patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Colombiana de Gastroenterologia

Print version ISSN 0120-9957


PRIETO ORTIZ, Jhon E; SANCHEZ PARDO, Santiago; ROJAS DIAZ, Leonardo  and  HUERTAS PACHECO, Sandra. Clinical Aspects of Fatty Liver Disease at a Tertiary Medical Center in Bogotá from 2009 to 2013. Rev Col Gastroenterol [online]. 2014, vol.29, n.2, pp.117-122. ISSN 0120-9957.

Introduction: Nonalcoholic fatty liver disease (NAFLD), or simply fatty liver, is a major cause of hepatic disease worldwide: its prevalence is approximately 30% in adults. In our environment the clinical characteristics of these patients are not known. Methodology: This was a descriptive and retrospective review of medical records from January 1, 2009 to May 31, 2013 of 266 patients diagnosed with fatty liver disease in the hepatology outpatient service at the Clínica Universitaria Colombia. Results: Of the 266 patients included in this study, 52.3 % were men and 47.7 % were women. The mean age at diagnosis was 51.6 years. The most frequently found antecedent of importance to the development of NAFLD was dyslipidemia which was found in 113 patients (42.5 %). 127 (47.8%) patients had nonalcoholic steatohepatitis (NASH), and 108 (40.6%) had simple steatosis. Thirty-one patients (11.6%) had cirrhosis which was classified according to CHILD scale: 22 (70.9%) were classified as A, 8 (25.8%) were classified as B, and one (3.2 %) was classified as C. Liver biopsies were taken from 31 patients (11.6%). Conclusions: Elements of metabolic syndrome, especially dyslipidemia, are often identified in our patients with FLD. Since most of these patients are in early stages of the disease with a low percentage of cirrhotic patients, it may be that the disease progresses more slowly in our environment than elsewhere. This is a hypothesis that should be validated in other studies

Keywords : Fatty liver; risk factors; NASH; NAFLD; hepatic steatosis; liver cirrhosis; fibrosis.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )